- Latest available (Revised)
- Original (As adopted by EU)
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
This version of this Decision was derived from EUR-Lex on IP completion day (31 December 2020 11:00 p.m.). It has not been amended by the UK since then. Find out more about legislation originating from the EU as published on legislation.gov.uk.![]()
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
1.The multi-annual programmes for the eradication of rabies submitted by the Czech Republic, Germany, Estonia, Latvia, Slovenia, and Finland are hereby approved for the period from:
(a)1 January 2008 to 31 December 2009 for the Czech Republic and Germany;
(b)1 January 2008 to 31 December 2010 for Latvia and Finland;
(c)1 January 2008 to 31 December 2011 for Estonia;
(d)1 January 2008 to 31 December 2012 for Slovenia.
2.The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out laboratory tests and for the purchase and distribution of vaccine plus baits for the programmes.
3.The maximum amounts of the costs to be reimbursed to the concerned Member State for the programmes referred to in paragraph 1 shall not exceed:
EUR 8 per test;
EUR 8 per test.
4.The contribution to cover the period for the implement of the multi-annual programmes shall not exceed:
(a)EUR 1 000 000 for the Czech Republic;
(b)EUR 800 000 for Germany;
(c)EUR 4 750 000 for Estonia;
(d)EUR 3 700 000 for Latvia;
(e)EUR 1 750 000 for Slovenia;
(f)EUR 300 000 for Finland.
5.The amounts to be committed for 2008 shall be:
(a)EUR 500 000 for the Czech Republic;
[F1(b) EUR 225 000 for Germany;
(c) EUR 860 000 for Estonia;
(d) EUR 700 000 for Latvia;
(e) EUR 380 000 for Slovenia;]
(f)EUR 100 000 for Finland.
6.The amounts to be committed for the following years shall be decided in function of the execution of the programme in 2008. An indication of these amounts (in euro) is given below:
| Member state | 2009 | 2010 | 2011 | 2012 |
|---|---|---|---|---|
| Czech republic | 500 000 | |||
| Germany | 325 000 | |||
| Latvia | 1 250 000 | 1 250 000 | ||
| Finland | 100 000 | 100 000 | ||
| Estonia | 1 250 000 | 1 250 000 | 1 250 000 | |
| Slovenia | 350 000 | 350 000 | 350 000 | 350 000 |
Textual Amendments
F1 Substituted by Commission Decision of 4 December 2008 approving certain amended programmes for the eradication and monitoring of animal diseases and zoonoses for the year 2008 and amending Decision 2007/782/EC as regards the reallocation of the Community’s financial contribution to certain Member States for programmes approved by that Decision (notified under document number C(2008) 7572) (2008/920/EC).
1.The multi-annual programme for the eradication of Aujeszky’s disease submitted by Belgium is hereby approved for the period from 1 January 2008 to 31 December 2009.
2.The financial contribution by the Community shall be at the rate of 50 % of the cost to be incurred by Belgium of carrying out laboratory tests.
3.The maximum amount of the costs to be reimbursed to Belgium for the programme referred to in paragraph 1 shall not exceed for an ELISA test EUR 1 per test.
4.The contribution to cover the period for the implementation of the multi-annual programme to be carried out by Belgium referred to in paragraph 1 shall not exceed EUR 720 000.
5.The amount to be committed for 2008 shall be EUR 360 000.
6.The amount to be committed for the following year shall be decided in function of the execution of the programme in 2008. EUR 360 000 is an indication thereof.
1.The multi-annual programmes for the eradication of enzootic bovine leucosis submitted by Italy, Latvia, and Portugal are hereby approved for the period from 1 January 2008 to 31 December 2010.
2.The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out laboratory tests and compensation to owners for the value of their animals slaughtered subject to those programmes.
3.The maximum amounts of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall not exceed:
EUR 0,5 per test;
EUR 0,5 per test.
4.The contribution to cover the period for the implementation of the multi-annual programmes shall not exceed:
(a)EUR 2 000 000 for Italy;
(b)EUR 170 000 for Latvia;
(c)EUR 1 000 000 for Portugal.
5.The amounts to be committed for 2008 shall be:
(a)[F1EUR 650 000] for Italy;
(b)EUR 60 000 for Latvia;
(c)[F1EUR 350 000] for Portugal.
6.The amounts to be committed for the following years shall be decided in function of the execution of the programme in 2008. An indication of these amounts (in euro) is given below:
| Member state | 2009 | 2010 | 2011 | 2012 |
|---|---|---|---|---|
| Italy | 800 000 | 800 000 | ||
| Latvia | 55 000 | 55 000 | ||
| Portugal | 350 000 | 350 000 |
Textual Amendments
F1 Substituted by Commission Decision of 4 December 2008 approving certain amended programmes for the eradication and monitoring of animal diseases and zoonoses for the year 2008 and amending Decision 2007/782/EC as regards the reallocation of the Community’s financial contribution to certain Member States for programmes approved by that Decision (notified under document number C(2008) 7572) (2008/920/EC).
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: